Devices Measuring Transepidermal Water Loss: A Systematic Review of Measurement Properties
Overview
Affiliations
Objective: The objective of this review is to examine the reliability and measurement error of devices that measure transepidermal water loss (TEWL).
Introduction: TEWL is a physiological property of skin which increases when the epidermis is damaged. It is, therefore, a commonly utilised measure of skin barrier integrity. Devices measuring TEWL are available as open, semi-open or closed chamber. Studies of reliability examine the consistency of measurement, and/or responsiveness whereas measurement error scores in absolute terms the amount of error due to sources of variation.
Inclusion Criteria: Studies examining the reliability and/or measurement error of TEWL measurement devices were included. Studies that only report on measurement of TEWL outcomes without examination of reliability and/or measurement error were excluded.
Methods: The search strategy aimed to locate published and unpublished studies. Databases searched included PubMed, Embase, CINAHL and Web of Science, utilising identified keywords and limited to studies in English. Grey literature sources were searched to identify any unpublished documents. Study selection using the inclusion criteria was then assessed by two reviewers for methodological quality utilising the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) risk of bias tool to assess the reliability and measurement error of outcome measurement instruments.
Results: A total of 22 devices were examined in the 38 included studies. The quality of study design was on average rated as 'Adequate' however reliability and measurement error statistical methods were on average rated as 'Doubtful'.
Discussion And Conclusion: TEWL measurement devices were found to demonstrate good reliability and frequently correlated with other devices. However, measurement error was highly variable but improves under in vitro conditions. Future research should consider risk of bias factors when designing studies.
Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.
Ribeiro A, Pereira-Leite C, Rosado C, Aruci E, Colley H, Kortekaas Krohn I JID Innov. 2025; 5(2):100340.
PMID: 39925780 PMC: 11803873. DOI: 10.1016/j.xjidi.2024.100340.
Handeland K, Wakeman M, Burri L J Cosmet Dermatol. 2024; 23(12):4285-4294.
PMID: 39169540 PMC: 11626371. DOI: 10.1111/jocd.16513.
Evaluation of in vitro Skin Permeation of Clascoterone From Clascoterone Topical Cream, 1% (w/w).
Yang Y, Wang J, Wanasathop A, Niu M, Ghosh P, Zidan A AAPS PharmSciTech. 2024; 25(6):186.
PMID: 39138712 DOI: 10.1208/s12249-024-02887-7.
Chaturvedi P, Kroon W, Zanelli G, Worsley P Skin Res Technol. 2024; 30(7):e13830.
PMID: 38951871 PMC: 11217022. DOI: 10.1111/srt.13830.
van den Brink N, Pardow F, Meesters L, van Vlijmen-Willems I, Rodijk-Olthuis D, Niehues H bioRxiv. 2024; .
PMID: 38562885 PMC: 10983962. DOI: 10.1101/2024.03.18.585587.